LRP1 Antibodies

Santa Cruz Biotechnology features a diverse variety of LRP1 monoclonal antibodies for advanced research in cellular biology. LRP1 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LRP1, or Low-Density Lipoprotein Receptor-Related Protein 1, plays a crucial role in endocytosis and the regulation of lipid metabolism, as well as in the clearance of various ligands, including apolipoproteins and proteases. LRP1's involvement in cellular signaling pathways makes it significant in processes such as inflammation, neurodegeneration, and cancer progression. Understanding LRP1 function is essential for elucidating its contributions to health and disease. Researchers worldwide rely on LRP1 monoclonal antibodies to investigate cellular mechanisms and pathways. Current studies focusing on LRP1 continue to reveal new insights about its role in various diseases and potential therapeutic applications. LRP1 research has opened new avenues for understanding cellular communication and disease progression. Santa Cruz Biotechnology monoclonal antibodies for LRP1 support researchers in advancing scientific knowledge and developing potential therapeutic strategies.